The paraventricular nucleus (PVN) of the hypothalamus contains corticotropin-releasing hormone (CRH) neurons that form the central axis of the hypothalamic-pituitary-adrenal (HPA) axis. These neurons coordinate the body's stress response and are critically involved in stress-related neurodegenerative processes .
- Structure: 41-amino acid peptide
- Gene: CRH gene on chromosome 8
- Family: CRH, urocortin, urotensin
- Receptors: CRHR1, CRHR2 (G-protein coupled)
¶ Synthesis and Release
- Pre-pro-CRH: 196 amino acid precursor
- Processing: Cleaved to mature CRH
- Secretion: Via median eminence into portal system
- Co-transmitters: Often with AVP
CRH neurons in PVN have:
- Parvocellular neurons: Small cell bodies (10-15 μm)
- Dendritic organization: Extend to median eminence
- Axonal projections: Median eminence, brainstem, limbic
- Synaptic inputs: From limbic structures, brainstem
- CRH: Corticotropin-releasing hormone
- CRHR1/CRHR2: Receptors
- AVP: Arginine vasopressin (co-expression)
- FOS: Activity marker
- GR (NR3C1): Glucocorticoid receptor
- Stress detection: CNS inputs trigger CRH release
- ACTH stimulation: Via median eminence to pituitary
- Cortisol/corticosterone release: Adrenal cortex activation
- Negative feedback: Cortisol inhibits CRH neurons
- Autonomic activation: Sympathetic tone
- Behavioral responses: Arousal, vigilance
- Metabolic effects: Glucose mobilization
- Immune modulation: Anti-inflammatory
- Food intake: Acute stress suppresses feeding
- Reproduction: Inhibits HPG axis
- Anxiety behaviors: CRH in extrahypothalamic circuits
Chronic Stress:
- HPA axis dysregulation in AD
- Elevated cortisol levels
- Hippocampal vulnerability
CRH Changes:
- Altered CRH in AD brain
- Affects amyloid processing
- Contributes to memory deficits
Therapeutic Implications:
- CRH receptor antagonists explored
- Stress reduction beneficial
Stress-Disease Interaction:
- Chronic stress worsens PD
- CRH may affect dopaminergic neurons
- HPA axis abnormalities reported
Neuroinflammation:
- CRH can modulate microglia
- May affect neuroinflammation
- Therapeutic target
¶ Depression and Anxiety
CRH Hyperactivity:
- Elevated CRH in depression
- CRH antagonists in trials
- Biomarker potential
Stress-Diathesis:
- Early stress increases risk
- CRH system in vulnerability
- Treatment implications
Acute Stress Response:
- Massive CRH release post-stroke
- Contributes to damage
- Therapeutic targeting
Recovery:
- CRH modulates plasticity
- Affects rehabilitation
CRH neurons are vulnerable due to:
- Glucocorticoid exposure: Chronic high cortisol
- Excitotoxicity: Glutamate sensitivity
- Energy demands: High synthetic load
- Aging: Declines with age
- PVN: Parvocellular and magnocellular divisions
- Bed nucleus stria terminalis: Extended amygdala
- Central amygdala: Stress circuits
- Cortex: Layer 6 (some populations)
- Brainstem: Parabrachial nucleus
- CRHR1 antagonists: Pexacerfont, verucerfont
- CRHR2 antagonists: Antalarmin
- In clinical trials for depression, anxiety
- Behavioral interventions
- Mindfulness, exercise
- Social support
- Glucocorticoid synthesis inhibitors
- GR agonists (negative feedback)
- Herbal compounds